Marc A. Becker insider trades: Concert Pharmaceuticals (CNCE) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Marc reports to the SEC
Open-market buys and sales
8 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 15, 2023 | CNCE | ↓ Sell | 3,762 | $8.33 | $31K | Direct | Feb 16, 2023 (1d) |
| Jan 30, 2023 | CNCE | ↓ Sell | 8,493 | $8.35 | $71K | Direct | Jan 31, 2023 (1d) |
| Jan 6, 2023 | CNCE | ↓ Sell | 2,893 | $7.25 | $21K | Direct | Jan 9, 2023 (3d) |
| Feb 14, 2022 | CNCE | ↓ Sell | 3,762 | $3.08 | $12K | Direct | Feb 16, 2022 (2d) |
| Jan 5, 2022 | CNCE | ↓ Sell | 2,894 | $3.20 | $9K | Direct | Jan 7, 2022 (2d) |
| Aug 16, 2021 | CNCE | ↓ Sell | 7,304 | $3.28 | $24K | Direct | Aug 17, 2021 (1d) |
| Feb 16, 2021 | CNCE | ↓ Sell | 3,763 | $7.32 | $28K | Direct | Feb 17, 2021 (1d) |
| Aug 17, 2020 | CNCE | ↓ Sell | 2,875 | $10.24 | $29K | Direct | Aug 19, 2020 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Marc A. Becker's insider trades
Marc A. Becker is Chief Financial Officer at Concert Pharmaceuticals (CNCE). Since Aug 17, 2020, Marc has reported no open-market purchases and 8 sales worth $225K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (5 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CNCE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.